Zacks Investment Research on MSN
J&J wins FDA nod for subcutaneous version of NSCLC drug Rybrevant (revised)
Johnson & Johnson JNJ announced that the FDA has approved the subcutaneous (under the skin or SC) formulation of its EGFR/MET ...
RejuvaCare FootRenew reports 1,900+ customer reviews as Triple Method heat-massage-compression devices gain market share ...
The next evolution of truFlex fortifies its position as a versatile solution for rehabilitation with new applications in functional strength for the abdomen, arms, calves, glutes and thighs.
Regeneron is finding ways to deal with the increased competition to one of its key growth drivers. The company is also ...
CUTERA, INC., a leading provider in aesthetic, dermatological solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted expanded indications for its truFlex muscle ...
Professors Guillermo Ameer and Cheng Sun contributed to work that points to a new approach for heart bypass grafts.
Investors say Microsoft's real edge comes from its sprawling AI ecosystem and growing independence from any single model ...
12d
“It’s Called The Mammalian Dive Reflex”: 50 Facts About The Human Body That Sound Fake But Aren’t
One of the biggest mistakes you can make in life is believing that you know everything there is to know. Even if you’re ...
Elite pickleball players, like Mumbai Smashers, master mental discipline, focus, and composure. Through mindset, recovery, ...
Worcester Polytechnic Institute researchers 3D print scaffolds for blood vessels - enabling the production of custom heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback